(0752–0778) Immunological Complications of Medical Therapy Poster

Sunday, November 13, 2022

9:00 AM – 10:30 AM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

9:00 AM – 10:30 AM Eastern Time

WITHDRAWN
9:00 AM – 10:30 AM Eastern Time

Humoral Immune Response Against BNT162b2 mRNA COVID-19 Vaccine in Patients with Rheumatic Disease Undergoing Immunosuppressive Therapy: A Japanese Monocentric Study
Abstract Poster Presenter: Koichi Sugihara, MD – Kagawa University
9:00 AM – 10:30 AM Eastern Time

Persistent but Disturbed Germinal Center Reaction Among 3^rd SARS-CoV-2 Vaccination After Rituximab Exposure
Abstract Poster Presenter: Ana-Luisa Stefanski, MD – Charite
9:00 AM – 10:30 AM Eastern Time

Immune Responses and Disease Marker Changes Following SARS-CoV-2 mRNA Vaccination in a Cohort of Rheumatic Disease Patients
Abstract Poster Presenter: Hu Zeng, PhD – Mayo Clinic
9:00 AM – 10:30 AM Eastern Time

Rheumatic Toxicities of Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and the Effect of Pre-existing Autoimmune and Non-immune Mediated Rheumatic Conditions
Abstract Poster Presenter: Alana Bruce, MBBS – Macquarie University
9:00 AM – 10:30 AM Eastern Time

Safety and Effectiveness of Immune Checkpoint Inhibitors Combination versus Single Agent Therapy in Patients with Pre-existing Autoimmune Diseases
Abstract Poster Presenter: Pankti Reid, MD, MPH – University of Chicago Medical Center
9:00 AM – 10:30 AM Eastern Time

Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE)-like Syndrome After Immune Checkpoint Inhibition: A CanRIO Study
Abstract Poster Presenter: Azin Rouhi, MD – University of Alberta
9:00 AM – 10:30 AM Eastern Time

Immunogenicity of COVID-19 Vaccines in Patients with Autoimmune and Inflammatory Rheumatic Diseases (AIIRD) on Immunomodulatory Therapies (IMT): An Updated Cohort Study
Abstract Poster Presenter: Gordon Lam, MD – Arthritis and Osteoporosis Consultants of the Carolinas
9:00 AM – 10:30 AM Eastern Time

Prevalence of Autoimmune Conditions in Metastatic Melanoma Patients Starting Checkpoint Inhibitors
Abstract Poster Presenter: Alexandra Ladouceur, MD, PhD – McGill University
9:00 AM – 10:30 AM Eastern Time

Identification of Outcome Domains in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and Polymyalgia Rheumatica: A Scoping Review by the OMERACT IrAE Working Group
Abstract Poster Presenter: Nilasha Ghosh, MD, MS – Hospital for Special Surgery
9:00 AM – 10:30 AM Eastern Time

Rituximab-treated Rheumatic Patients: B-cell Levels Predict Sero-conversion After COVID-19 Boost or Re-vaccination in Initial Vaccine Non-responders
Abstract Poster Presenter: Christian Ammitzbøll, MD, PhD – Aarhus University Hospital
9:00 AM – 10:30 AM Eastern Time

Immunogenicity Analysis from the VOLTAIRE Trials in Patients with Rheumatoid Arthritis, Crohn’s Disease, and Chronic Plaque Psoriasis
Abstract Poster Presenter: Vibeke Strand, MD, FACP, MACR – Stanford University School of Medicine, Palo Alto CA
9:00 AM – 10:30 AM Eastern Time

No Impact of Prior DMARD Exposures on Mortality in US Veterans with Cancer Treated with Immune Checkpoint Inhibitors
Abstract Poster Presenter: Tawnie Braaten, MD – UNIVERSITY OF UTAH
9:00 AM – 10:30 AM Eastern Time

WITHDRAWN
9:00 AM – 10:30 AM Eastern Time

CCP+ Immune Checkpoint Inhibitor Arthritis Patients Have Less ACPA Epitope Expansion Than CCP+ Rheumatoid Arthritis Patients
Abstract Poster Presenter: Nilasha Ghosh, MD, MS – Hospital for Special Surgery
9:00 AM – 10:30 AM Eastern Time

Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO) - A Retrospective Chart Review Study of Adults with Inflammatory Arthritis Associated with Cancer Immunotherapies
Abstract Poster Presenter: Brooke Pollock, MD – University of Toronto
9:00 AM – 10:30 AM Eastern Time

Reevaluating Clinical Outcomes of Patients on Combination Biologics
Abstract Poster Presenter: Ryan Mathew, MD – Clinic For Rheumatic Diseases
9:00 AM – 10:30 AM Eastern Time

Heterologous Vector versus Homologous mRNA COVID-19 Booster Vaccination in Non-seroconverted Immunosuppressed Patients: A Randomized Controlled Trial
Abstract Poster Presenter: Daniela Sieghart, PhD – Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
9:00 AM – 10:30 AM Eastern Time

Immune Related Adverse Events in Checkpoint Inhibitor Treated Cancer Patients Increased in Patients with Underlying Autoimmune Disease and Positive Autoantibodies
Abstract Poster Presenter: Amarah Baluch, MD, BSc – SUNY Upstate Medical University
9:00 AM – 10:30 AM Eastern Time

The Use of a bDMARD or tsDMARD for the Management of Rheumatic irAE Under Checkpoint Inhibitors: An Observational Study
Abstract Poster Presenter: Fanny De La Fuente, MD – Bordeaux University Hospital
9:00 AM – 10:30 AM Eastern Time

New Onset Rheumatologic Syndromes After Covid-19 Vaccination: Systematic Review
Abstract Poster Presenter: Luis Javier Jara Quezada, MD – INSTITUTO NACIONAL DE REHABILITACION LUIS GUILLERMO IBARRA IBARRA
9:00 AM – 10:30 AM Eastern Time

Additional Dose of SARS-CoV-2 Vaccine Improves Cross-Variant Neutralization Titers in Immunosuppressed Patients with Chronic Inflammatory Disease
Abstract Poster Presenter: Michael Paley, MD, PhD – Washington University in St. Louis
9:00 AM – 10:30 AM Eastern Time

HLA-DQ2 Is Associated with Anti-drug Antibody Formation to Infliximab Across Immune-mediated Inflammatory Diseases
Abstract Poster Presenter: Guro L. Goll, MD, PhD – Diakonhjemmet Hospital
9:00 AM – 10:30 AM Eastern Time

The Distribution and Frequency of Autoreactive B Cells Are Altered in Autoimmune Patients After TNF Inhibitor Treatment
Abstract Poster Presenter: Tam Quach, PhD – Feinstein Institute for Medical Research
9:00 AM – 10:30 AM Eastern Time

Expert Clinical Management of Immune-related Inflammatory Arthritis: Results from a Multicenter International Expert Survey
Abstract Poster Presenter: Sebastian Bruera, MD – Baylor College of Medicine
9:00 AM – 10:30 AM Eastern Time

Immune Checkpoint Inhibition and Preexisting Autoimmune Disease: A Retrospective Cohort Study
Abstract Poster Presenter: Arjun athreya Raghavan, BSc – University of Manitoba Max Rady College of Medicine
9:00 AM – 10:30 AM Eastern Time

TNF Inhibitors Display a Modulatory Effect on Serological and Cellular Vaccine Response in Patients with Chronic Inflamatory Diseases
Abstract Poster Presenter: Bimba Hoyer, MD – UKSH Kiel